Bill Ackman named to Valeant board
Beleaguered hedge fund titan Bill Ackman wanted more control of Valeant Pharmaceuticals (VRX)—and he just got it—but probably not in the way he wanted it to go down. After losing 75% of its share price this year, Valeant announced this morning that CEO Mike Pearson would be stepping down and that Ackman will get a board seat. Will it be enough to save Ackman's Pershing Square funds?
抄底要谨慎。。。。。。
